返回成功案例
医疗健康

MediCA group has been acquired by Repharm

CGP Management has sold MediCA group, the largest private provider of healthcare services in Lithuania, to Repharm.

MediCA group is present in all levels of the healthcare system with primary, specialist and hospital care being the core business areas. Primary and selected specialist care services are provided in 30 clinics across Lithuania under the brand name MediCA. Kardiolitos Klinikos, which is the only private hospital in Lithuania, has three specialist centers, located in Vilnius, Kaunas, and Šiauliai, providing inpatient and outpatient healthcare services and is a nationally acknowledged center of excellence for cardiology services.

Repharm is a Latvian group of companies providing a wide range of healthcare services, from healthy lifestyle counseling to diagnosis and treatment. The group includes Sentor Farm Aptiekas (pharmacies operating under the Mēness Aptieka brand), Veselības Centru Apvienība (a chain of private clinics), Centrālā Laboratorija (a medical laboratory), Rīgas farmaceitiskā fabrika (a manufacturer of galenic preparations, soft pharmaceuticals and herbal drugs and teas) and Recipe Plus (wholesale trader of pharmaceutical and healthcare products).

Oaklins’ team in Lithuania advised CGP Management on the sale of MediCA group to Repharm.

我们的服务
卖方并购
交易方
“We have worked with Oaklins on various M&A processes for a number of years. The team have proved themselves to be very efficient and inventive financial advisors that we could always rely on. The results achieved during the MediCa sale process have far exceeded our expectations with regard to the competition and final deal terms. We are looking forward to working on more projects with the Oaklins team.”

Alvydas Barsteiga

Member of the Board, CGP Management

联系交易团队

Natalja Titova

Natalja Titova

副合伙人
维尔纽斯, 立陶宛
Oaklins Baltics
查看简介 联系我们
Mindaugas Matulaitis

Mindaugas Matulaitis

副合伙人
维尔纽斯, 立陶宛
Oaklins Baltics
查看简介 联系我们

相关交易

Bayer AG has entered into a takeover agreement with Cara Care
医疗健康 | 科技、媒体及通讯

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

更多信息
Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
医疗健康

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.

更多信息
Creo Medical Group plc has completed a US$15.7 million equity fundraise
医疗健康

Creo Medical Group plc has completed a US$15.7 million equity fundraise

Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.

更多信息